Evidence map›Paper›PMID 41728619›Full record

ArticleFrontiers in medicine2026

Molecular pattern of acquiring upper respiratory infection.

Mohamed A Hendaus

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mohamed A HendausThe View Hospital, in Affiliation with Cedar's Sinai, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upper respiratory tract infections (URIs) are a significant public health concern. Human behavior plays a crucial role in how often infected individuals come into contact with susceptible individuals. Among the key factors influencing the seasonality of these infections, variations in temperature and absolute humidity are critical elements driving the increase in respiratory virus infections, particularly during the winter months. Traditionally, it has been believed that cold and flu viruses thrive in winter mainly because falling temperatures lead to people spending more time indoors, which facilitates easier transmission. However, compelling evidence suggests that biological factors also contribute to the increased risk of illness in colder weather. Recent studies indicate that active mucosal defenses against bacteria extend into the mucus itself, aided by the epithelial release of antimicrobial extracellular vesicle (EV) swarms. Unfortunately, these studies have also shown that EVs are significantly weakened by exposure to cold environments.

Indexed as

coldextracellular vesicle swarmsimmunityupper respiratory infectionwinter

Identifiers

PMID41728619
PMCPMC12920469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.